MONDAY, Aug. 16, 2021 (HealthDay News) — COVID-19 vaccination triggers a strong immune response in people with HIV, meaning they’re likely protected against the coronavirus, a new, small study shows. “Previous research has suggested a suboptimal response to COVID-19 vaccines in people living with HIV; however, these studies did notContinue Reading

THURSDAY, Aug. 12, 2021 (HealthDay News) — When the antiretroviral regimen known as pre-exposure prophylaxis, or PrEP, was launched nearly a decade ago, patients were suddenly able to achieve near-complete protection against contracting HIV by taking just one pill a day. But there’s a big hitch: Not everyone is equallyContinue Reading

THURSDAY, Aug. 5, 2021 (HealthDay News) — The two HIV prevention drugs available in the United States are equally safe and effective, and the biggest difference between them is price, a new study contends. However, a sizable minority of patients have switched from the older and cheaper “preexposure prophylaxis” (PrEP)Continue Reading